Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
PaperCitations, authors & open-access status
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 226 citations, 2020 year and hybrid oa status.
226
Citations
2020
Year
hybrid
OA Status